Quest Diagnostics Incorporated DGX

236.32 (0.27) (0.11%) as of 25 Sep

Market cap: $26.2B
P/E: 24.8×

Follow DGX

S&P 500 Member Dividend Champion (5y)

Indexes indicate stock being part of an index,

Growth Flags show if company had growth for consecutive years

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25
P/E ratio	20.23	17.57	15.45	16.79	11.24	10.90	19.33	18.55	19.39	19.56
P/S ratio	1.79	1.83	1.50	1.85	1.69	2.00	1.83	1.70	1.70	1.75
P/FCF ratio	15.73	14.68	13.86	16.97	10.06	11.82	13.75	18.25	18.42	14.17
P/Operating CF	36.87	41.95	38.39	41.12	29.52	44.96	54.10	29.93	36.09	41.42
P/B ratio	2.78	2.73	2.15	2.52	2.35	3.34	3.05	2.49	2.46	2.67
Price to Tangible BV	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EV/Sales	2.26	2.32	2.00	2.32	1.99	2.30	2.20	2.14	2.27	2.22
EV/EBITDA	10.69	11.98	10.70	11.47	8.07	8.88	11.65	11.64	12.19	11.53
EV/Operating CF	14.62	14.64	12.57	14.39	9.39	11.09	12.65	15.57	16.80	13.00
EV/FCF	19.83	18.63	18.46	21.22	11.86	13.53	16.54	22.92	24.66	18.04
Quick Ratio	1.31	1.00	0.77	1.13	1.51	1.32	0.97	1.04	0.85	0.80
Current Ratio	1.56	1.24	0.94	1.25	1.72	1.56	1.22	1.31	1.10	1.04
Net Debt/EBITDA	2.21	2.54	2.67	2.29	1.23	1.13	1.97	2.37	3.08	2.47
Debt/Assets	36.97%	36.03%	35.38%	37.14%	28.63%	29.48%	31.00%	33.61%	38.49%	34.95%
Debt/Equity	0.80	0.76	0.74	0.84	0.59	0.62	0.67	0.74	0.91	0.79
Asset Turnover	0.72	0.72	0.70	0.65	0.70	0.78	0.75	0.69	0.65	0.68
Operating CF/Net income	1.74	1.52	1.63	1.45	1.41	1.12	1.82	1.50	1.54	1.91
Capex/Depreciation	(1.18)	(0.93)	(1.24)	(1.22)	(1.16)	(0.99)	(0.92)	(0.93)	(0.86)	(0.92)
Interest Coverage	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ROE	13.70%	16.06%	14.40%	15.67%	22.81%	29.91%	15.18%	13.85%	13.17%	14.10%
ROA	6.40%	7.49%	6.84%	7.20%	10.61%	14.39%	7.12%	6.33%	5.74%	6.10%
ROIC	9.93%	8.46%	7.62%	8.30%	12.74%	15.46%	9.30%	7.61%	6.74%	7.81%
Return on Tangible Assets	40.66%	55.38%	61.69%	43.93%	48.99%	73.77%	44.58%	35.82%	37.07%	42.90%
Average Days of Receivables	46.85	45.56	49.05	50.22	58.79	48.65	44.13	47.74	48.21	46.57
Research and Development Expense of Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue	19.13%	19.49%	18.91%	18.86%	16.42%	16.01%	18.96%	17.75%	17.93%	17.83%
Intangible Assets out of Total Assets	0.69	0.71	0.71	0.60	0.57	0.61	0.65	0.63	0.66	0.65
Share Based Compensation of Revenue	0.96%	1.07%	0.81%	0.72%	1.03%	0.73%	0.78%	0.83%	0.89%	0.80%
Graham Net Nets	(0.30)	(0.31)	(0.38)	(0.33)	(0.26)	(0.20)	(0.28)	(0.34)	(0.41)	(0.34)
Graham Number	58.50	67.69	68.53	77.93	110.09	136.09	96.28	98.34	103.65	113.83
Earnings Yield	4.94%	5.69%	6.47%	5.96%	8.89%	9.17%	5.17%	5.39%	5.16%	5.11%
Free Cash Flow Yield	6.36%	6.81%	7.21%	5.89%	9.94%	8.46%	7.27%	5.48%	5.43%	7.06%
Revenue per Share	51.53	54.03	55.38	57.66	70.43	86.30	85.20	82.61	88.94	99.41
Operating CF per Share	7.97	8.58	8.82	9.28	14.96	17.86	14.81	11.36	12.02	16.99
Capex per Share	(2.09)	(1.84)	(2.82)	(2.99)	(3.12)	(3.22)	(3.48)	(3.64)	(3.83)	(4.75)
Free Cash Flow per Share	5.88	6.74	6.01	6.29	11.84	14.64	11.33	7.71	8.19	12.24
Cash per Share	2.56	1.00	0.99	8.90	8.64	6.98	2.72	6.13	4.95	3.78
Shareholders Equity per Share	33.29	36.17	38.73	42.44	50.81	51.86	51.12	56.63	61.38	64.92
Interest Debt per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per Share	33.29	36.17	38.73	42.44	50.81	51.86	51.12	56.63	61.38	64.92
Free Cash Flow	823.00	923.00	817.00	843.00	1,587.00	1,830.00	1,314.00	864.00	909.00	1,359.00
Working Capital	550.00	249.00	(95.00)	500.00	1,282.00	988.00	347.00	557.00	223.00	100.00
Capital Expenditures	(293.00)	(252.00)	(383.00)	(400.00)	(418.00)	(403.00)	(404.00)	(408.00)	(425.00)	(527.00)
Net Current Asset Value	(3,909.00)	(4,242.00)	(4,346.00)	(4,666.00)	(4,159.00)	(4,387.00)	(5,009.00)	(5,308.00)	(6,948.00)	(6,641.00)
EV/EBIT	12.78	14.76	13.70	14.53	9.55	10.40	15.22	15.69	16.65	15.75
Capex to Sales	0.04	0.03	0.05	0.05	0.04	0.04	0.04	0.04	0.04	0.05
Net Profit Margin	8.90%	10.43%	9.77%	11.11%	15.10%	18.43%	9.53%	9.19%	8.77%	8.95%
Price to Operating Income	10.14	11.63	10.29	11.62	8.10	9.08	12.65	12.50	12.44	12.38
Other line items
Depreciation/Fixed assets	0.24	0.24	0.24	0.23	0.22	0.24	0.25	0.24	0.23	0.26
Cash ROIC	0.99%	0.34%	(0.95%)	(1.80%)	3.15%	4.63%	(0.47%)	(4.63%)	(5.74%)	(2.38%)
Accounts Receivable Turnover	7.90	8.00	7.78	7.45	7.31	7.29	7.51	7.69	7.85	8.14
Accounts Payable Turnover	4.64	4.73	4.82	4.89	4.34	4.07	4.31	4.50	4.82	4.92
Inventory Turnover	55.61	53.32	50.78	45.38	33.55	30.53	32.25	32.46	35.07	39.10
Average Days of Payables	77.10	78.97	75.65	75.43	102.70	88.77	79.00	80.02	76.77	79.24
Days of Inventory on Hand	6.48	7.35	7.34	8.91	14.02	11.54	10.87	11.19	10.35	9.36
Average Receivables	913.50	925.00	968.00	1,037.50	1,291.50	1,479.00	1,316.50	1,202.50	1,257.00	1,356.00
Average Payables	994.50	998.00	1,021.00	1,031.00	1,337.00	1,616.50	1,498.00	1,377.50	1,376.50	1,497.00
Average Inventory	83.00	88.50	97.00	111.00	173.00	215.50	200.00	191.00	189.00	188.50
Average Assets	10,031.00	10,301.50	10,753.00	11,923.00	13,434.50	13,818.50	13,224.00	13,429.50	15,087.50	16,189.00
Average Common Equity	4,686.50	4,807.50	5,111.00	5,477.00	6,248.00	6,646.00	6,206.50	6,136.00	6,577.50	7,009.50

Show all line items

Columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

Quest Diagnostics Incorporated DGX